Katarina Ejeskar
Overview
Explore the profile of Katarina Ejeskar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Luca F, Nilsson S, Truve K, Kuhn H, Ejeskar K, Haraldsson B, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):125.
PMID: 40025438
Background: coeliac disease (CD) is an inflammatory condition of the small intestine caused by immunological intolerance towards dietary gluten. Associations between CD and other autoimmune disorders have been extensively reported....
2.
Maroofian R, Kaiyrzhanov R, Cali E, Zamani M, Zaki M, Ferla M, et al.
Brain
. 2023 Jul;
146(12):5031-5043.
PMID: 37517035
MED27 is a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation. Biallelic MED27 variants have recently been suggested to be responsible for an autosomal recessive neurodevelopmental...
3.
Lindholm H, Ejeskar K, Szekeres F
Med Int (Lond)
. 2023 Jan;
2(5):27.
PMID: 36698913
The alpha subunits (ATP1A1-3) of Na/K-ATPase binds digitoxin with varying affinity. The expression levels of these subunits dictate the anticancer effects of digitoxin. In the present study, three pancreatic cancer...
4.
Jurcevic S, Keane S, Borgmastars E, Lubovac-Pilav Z, Ejeskar K
Sci Rep
. 2022 Nov;
12(1):19729.
PMID: 36396668
Neuroblastoma is a childhood tumour that is responsible for approximately 15% of all childhood cancer deaths. Neuroblastoma tumours with amplification of the oncogene MYCN are aggressive, however, another aggressive subgroup...
5.
Deland L, Keane S, Bontell T, Fagman H, Sjogren H, Lind A, et al.
Cancer Genomics Proteomics
. 2022 Oct;
19(6):711-726.
PMID: 36316040
Background/aim: Although fusion genes involving the proto-oncogene receptor tyrosine kinase ROS1 are rare in pediatric glioma, targeted therapies with small inhibitors are increasingly being approved for histology-agnostic fusion-positive solid tumors....
6.
Lindholm H, Ejeskar K, Szekeres F
Int J Mol Sci
. 2022 Jul;
23(15).
PMID: 35897809
Digitoxin has repeatedly shown to have negative effects on cancer cell viability; however, the actual mechanism is still unknown. In this study, we investigated the effects of digitoxin (1-100 nM)...
7.
Keane S, Herring M, Rolny P, Wettergren Y, Ejeskar K
J Cancer Res Clin Oncol
. 2022 May;
148(9):2295-2311.
PMID: 35499706
Purpose: Loss of expression of DLG2 has been identified in a number of cancers to contribute to the disease by resulting in increased tumor cell proliferation and poor survival. In...
8.
Keane S, de Weerd H, Ejeskar K
DNA Repair (Amst)
. 2022 Feb;
112:103302.
PMID: 35217496
Background: In primary neuroblastoma, deletions on chromosome 11q are known to result in an increase in the total number of chromosomal breaks. The DNA double-strand break repair pathways mediated by...
9.
Pagnamenta A, Diaz-Gonzalez F, Banos-Pinero B, Ferla M, Toosi M, Calder A, et al.
J Med Genet
. 2021 Nov;
59(10):947-950.
PMID: 34782440
No abstract available.
10.
Deland L, Keane S, Bontell T, Sjogren H, Fagman H, Ora I, et al.
Cancer Biol Ther
. 2021 Apr;
22(3):184-195.
PMID: 33820494
Here we report a case of an 11-year-old girl with an inoperable tumor in the optic chiasm/hypothalamus, who experienced several tumor progressions despite three lines of chemotherapy treatment. Routine clinical...